摘要
Background & Aims: Pre-acute-on-chronic liver failure (ACLF) is a distinct intermediate stage between acute decompensation (AD) and ACLF. However, identifying patients with pre-ACLF and predicting progression from AD to ACLF is difficult. This study aimed to identify pre-ACLF within 28 days, and to develop and validate a prediction model for ACLF in patients with HBV-related decompensated cirrhosis. @@@ Methods: In total, 1,736 patients with HBV-related cirrhosis and AD were enrolled from 2 large-scale, multicenter, prospective cohorts. ACLF occurrence within 28 days, readmission, and 3-month and 1-year outcomes were collected. @@@ Results: Among 970 patients with AD without ACLF in the derivation cohort, the 94 (9.6%) patients with pre-ACLF had the highest 3-month and 1-year LT-free mortality (61.6% and 70.9%, respectively), which was comparable to those with ACLF at enrollment (57.1% and 67.1%); the 251 (25.9%) patients with unstable decompensated cirrhosis had mortality rates of 22.4% and 32.1%, respectively; while the 507 (57.9%) patients with stable decompensated cirrhosis had the best outcomes (1-year mortality rate of 2.6%). Through Cox proportional hazard regression, specific precipitants, including hepatitis B flare with HBV reactivation, spontaneous hepatitis B flare with high viral load, superimposed infection on HBV, and bacterial infection, were identified to be significantly associated with ACLF occurrence in the derivation cohort. A model that incorporated precipitants, indicators of systemic inflammation and organ injuries reached a high C-index of 0.90 and 0.86 in derivation and validation cohorts, respectively. The optimal cut-off value (0.22) differentiated high-risk and low-risk patients, with a negative predictive value of 0.95. @@@ Conclusions: Three distinct clinical courses of patients with AD are validated in the HBV-etiology population. The precipitants significantly impact on AD-ACLF transition. A model developed by the precipitant-systemic inflammation-organ injury framework could be a useful tool for predicting ACLF occurrence. @@@ Lay summary: It was previously shown that patients with decompensated cirrhosis could be stratified into 3 groups based on their short-term clinical prognoses. Herein, we showed that this stratification applies to patients who develop cirrhosis as a result of hepatitis B virus infection. We also developed a precipitant-based model (i.e. a model that incorporated information about the exact cause of decompensation) that could predict the likelihood of these patients developing a very severe liver disease called acute-on-chronic liver failure (or ACLF).
学科与关键词
- Prognosis prediction performs better in patients with non-cirrhosis hepatitis B virus-related acute-on-chronic liver failure than those with cirrhosisYu, Xia; Li, Hai; Tan, Wenting; Wang, Xianbo; Zheng, Xin; Huang, Yan; Li, Beiling; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shang, Jia; Yan, Huadong; Zheng, Yubao; Zhang, Weituo; Yin, Shan; Gu, Wenyi; Deng, Guohong; Xiang, Xiaomei; Zhou, Yi; Hou, Yixin; Zhang, Qun; Xiong, Shue; Liu, Jing; Chen, Ruochan; Long, Liyuan; Chen, Jinjun; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Jiang, Chang; Zhao, Jinming; Ji, Liujuan; Mei, Xue; Li, Jing; Li, Tao; Zheng, RongjiongFrontiers in Microbiology, 2022, 13: 1013439.被引 1
- MELD score < 18 rule out 28-day ACLF development among inpatients with hepatitis B-related previous compensated liver diseaseQi, Tingting; Zhu, Congyan; Wang, Jiapeng; Li, Beiling; Huang, Zuxiong; Zhu, Zhibin; Tu, Minghan; Deng, Guohong; Zheng, Xin; Huang, Yan; Meng, Zhongji; Wang, Xianbo; Qian, Zhiping; Li, Hai*; Gao, Yanhang; Liu, Feng; Shang, Jia; Shi, Yu; Lu, Xiaobo; Wang, Shaoyang; Chen, Jinjun*Journal of Viral Hepatitis, 2022, 29(12): 1089-1098.
- Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology OrganizationTang, Xiaoting; Qi, Tingting; Li, Beiling; Li, Hai; Huang, Zuxiong; Zhu, Zhibin; Tu, Minghan; Gao, Jie; Zhu, Congyan; Jiang, Xiuhua; Yu, Xutong; Lu, Guanting; Xiong, Ming; He, Qinjun; Zhou, Fuyuan; Wen, Weiqun; Chen, Jinjun*; Hou, JinlinJournal of Gastroenterology and Hepatology, 2021, 36(1): 208-216.被引 9
